Legislation to facilitate and fund psychedelics research has gained a new sponsor in the US House of Representatives.
The Douglas “Mike” Day Psychedelic Therapy to Save Lives Act of 2023 (H.R. 3684) was filed in May by Congressmember Dan Crenshaw (R-TX) along with 11 bipartisan cosponsors. Since then, the measure has gained five new sponsors, with Rep Yakym the first new sponsor for the bill in almost six months.
This legislation “requires the Department of Defense (DOD) to award grants to eligible entities to research the treatment of certain members of the Armed Forces through the use of specified psychedelic substances (e.g., MDMA).”
Continue reading